Anti-cyclic citrullinated peptide antibodies in scleroderma patients

Clinical Rheumatology

Volumn 31, Issue 5, 2012, Pages 877-880

  Polimeni, M ^a   Feniman, D ^a   Skare, T S ^a   Nisihara, Renato M ^a,b  

^a Evangelical University Hospital of Curitiba   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Anti CCP; Arthralgia; Scleroderma

Indexed keywords

CENTROMERE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; SCLERODERMA; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMYOSITIS; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SEROEPIDEMIOLOGIC STUDIES;

EID: 84863715546     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1930-z     Document Type: Article

References (19)

1. Misra R, Darton K, Jewkes RF, Black CM, Maini RN (1995) Arthritis in scleroderma. Br J Rheumatol 34:831-837
2. La Montagna G, Solano A, Capurro V, Malesci D, Valentini G (2005) The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 34:35-41
3. Ingegnoli F, Galbiati V, Zeni S et al (2007) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26:510-514
4. Blocka KN, Basset LW, Furst DE, Clements PJ, Paulus HE (1981) The arthropathy of advanced progressive systemic sclerosis. A radiographic survey. Arthritis Rheum 24:874-884
5. Ioan-Facsinay A,WillemzeA, Robinson DB, Peschken CA, Markland J, van der Woude D et al (2008) Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum 58:3000-3008
6. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797-808
7. Cui J, Taylor KE, Destefano AL, Criswell LA, Izmailova ES, Parker A et al (2009) Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis. J Mol Med 15:136-143
8. Santiago M, Baron M, Miyachi K et al (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP-3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27:77-83
9. Moryta Y, Muro K, Sugiura K, Tomita Y (2008) Anti citrullinated peptide antibody in systemic sclerosis. Clin Exp Rheumatol 26:542-547
10. Subcommitee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
11. Furst DE, Clements PJ, Wong WK, Mayes MD, Wigley F, White BE et al (2001) Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatol 40:615-622
12. Denton CP, Black CM (2003) Pulmonary hypertension in systemic sclerosis. Rheuma Dis Clin N Am 29:335-349
13. Akenson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2003) The assessment of the patient with systemic sclerosis. The assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(3 Suppl 29):S5-S8
14. Bassotti G, Battaglia E, Debernardi V, Germani U, Quiriconi F, Dughera L et al (1997) Esophageal dysfunction in scleroderma. Arthritis Rheum 40:2252-2259
15. Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159-2167
16. Szücs G, Szekanecz Z, Zilahi E et al (2007) Systemic sclerosisrheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetics serological and clinical entity. Rheumatology 46:989-993
17. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smoles JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis. Arthritis Rheum 41:1936-1945
18. Rodnan GP (1962) The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma). Ann Inter Med 56:422-439
19. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (2010) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology 49:1590-1593